EL
FLNA

Essex LLC’s Filana Therapeutics FLNA Stock Holding History

Essex LLC’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-58,552
Closed -$138K – 176
2024
Q4 		$138K Sell
58,552
-11,222
-16% -$197K 0.03% 168
2024
Q3 		$2.05M Buy
69,774
+14,456
+26% +$333K 0.42% 58
2024
Q2 		$683K Buy
55,318
+4,644
+9% +$97.9K 0.15% 100
2024
Q1 		$1.03M Buy
50,674
+15,900
+46% +$366K 0.24% 78
2023
Q4 		$783K Buy
34,774
+22,620
+186% +$478K 0.19% 87
2023
Q3 		$202K Sell
12,154
-4,760
-28% -$94.3K 0.06% 158
2023
Q2 		$415K Buy
16,914
+1,713
+11% +$41.3K 0.12% 105
2023
Q1 		$449K Hold
15,201
– – 0.14% 106
2022
Q4 		$449K Sell
15,201
-7,468
-33% -$268K 0.14% 106
2022
Q3 		$948K Buy
22,669
+10,145
+81% +$274K 0.31% 78
2022
Q2 		$352K Buy
12,524
+467
+4% +$11.8K 0.11% 117
2022
Q1 		$448K Buy
12,057
+1,397
+13% +$59.2K 0.12% 120
2021
Q4 		$466K Sell
10,660
-2,624
-20% -$138K 0.12% 120
2021
Q3 		$825K Buy
+13,284
New +$1.11M 0.23% 89

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Essex LLC's FLNA Position: Q1 2025 in Review

Essex LLC sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 58,552 shares — an estimated $138K sold.

Essex LLC first reported a position in FLNA in Q3 2021 and held it in 14 quarters. The position peaked at $2.05M in Q3 2024. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

  • Essex LLC reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Essex LLC sold 58,552 Filana Therapeutics shares in Q1 2025, an estimated $138K.
  • Essex LLC first reported a position in Filana Therapeutics in Q3 2021 and held it in 14 quarters.
  • Essex LLC's Filana Therapeutics position peaked at $2.05M in Q3 2024.
  • 117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on Essex LLC's 13F filing for Q1 2025, filed 25 Apr 2025.